Celgene, Bristol-Myers set $2.2 bn termination fee for mega deal
Celgene Corp and Bristol-Myers Squibb Co will have to pay $2.2 billion if either of the drug makers walks away from their $74 billion merger announcement according to a regulatory filing.
